BiotechTube
Home/Corbus Pharmaceuticals/Yuval Cohen, Ph.D.
YC

Yuval Cohen, Ph.D.

Chief Executive Officer and Director

Corbus Pharmaceuticals

Therapeutic Areas

OncologyMetabolic Disease

Corbus Pharmaceuticals Pipeline

DrugIndicationPhase
CRB-701Nectin-4 expressing solid tumors (e.g., Cervical Cancer, HNSCC, mUC)Phase 1
CRB-913Obesity and related conditionsPhase 1

Leadership Team at Corbus Pharmaceuticals

SM
Sean Moran, CPA, MBA
Chief Financial Officer
DD
Dr. Dominic Smethurst, MA MRCP
Chief Medical Officer
IH
Ian Hodgson, BSc (Hons), Ph. D.
Chief Operating Officer
View full Corbus Pharmaceuticals profile